SaintMed Valuation
Is SMD-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SMD-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SMD-R (THB6.6) is trading above our estimate of fair value (THB5.4)
Significantly Below Fair Value: SMD-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SMD-R?
Other financial metrics that can be useful for relative valuation.
What is SMD-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿1.37b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.3x |
Enterprise Value/EBITDA | 9.5x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does SMD-R's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 29.9x | ||
BIS Bioscience Animal Health | 20.4x | n/a | ฿1.0b |
WINMED Winnergy Medical | 32.4x | n/a | ฿992.0m |
BIZ Business Alignment | 10.3x | n/a | ฿2.1b |
EFORL E for L Aim | 56.6x | n/a | ฿759.7m |
SMD-R SaintMed | 17.3x | n/a | ฿1.4b |
Price-To-Earnings vs Peers: SMD-R is good value based on its Price-To-Earnings Ratio (17.3x) compared to the peer average (29.9x).
Price to Earnings Ratio vs Industry
How does SMD-R's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Earnings vs Industry: SMD-R is good value based on its Price-To-Earnings Ratio (17.3x) compared to the TH Healthcare industry average (26.8x).
Price to Earnings Ratio vs Fair Ratio
What is SMD-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 17.3x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SMD-R's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.